Colgate-Palmolive Company $CL Shares Acquired by Elo Mutual Pension Insurance Co

Elo Mutual Pension Insurance Co lifted its position in Colgate-Palmolive Company (NYSE:CLFree Report) by 33.7% during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 106,068 shares of the company’s stock after acquiring an additional 26,713 shares during the period. Elo Mutual Pension Insurance Co’s holdings in Colgate-Palmolive were worth $8,479,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other hedge funds have also recently added to or reduced their stakes in the company. Westside Investment Management Inc. boosted its stake in Colgate-Palmolive by 85.5% during the 2nd quarter. Westside Investment Management Inc. now owns 282 shares of the company’s stock worth $26,000 after purchasing an additional 130 shares during the last quarter. Copia Wealth Management purchased a new position in shares of Colgate-Palmolive in the third quarter worth about $29,000. Vermillion & White Wealth Management Group LLC lifted its stake in shares of Colgate-Palmolive by 86.1% in the second quarter. Vermillion & White Wealth Management Group LLC now owns 335 shares of the company’s stock worth $30,000 after buying an additional 155 shares in the last quarter. Cloud Capital Management LLC acquired a new position in Colgate-Palmolive during the third quarter worth about $30,000. Finally, MTM Investment Management LLC purchased a new stake in Colgate-Palmolive during the 2nd quarter valued at about $39,000. 80.41% of the stock is owned by institutional investors and hedge funds.

Insider Transactions at Colgate-Palmolive

In other Colgate-Palmolive news, insider John Hazlin sold 20,989 shares of the business’s stock in a transaction dated Tuesday, February 10th. The shares were sold at an average price of $94.25, for a total transaction of $1,978,213.25. Following the sale, the insider directly owned 17,645 shares in the company, valued at $1,663,041.25. This represents a 54.33% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, CFO Stanley J. Sutula III sold 97,843 shares of the firm’s stock in a transaction that occurred on Wednesday, February 4th. The shares were sold at an average price of $94.27, for a total transaction of $9,223,659.61. Following the completion of the transaction, the chief financial officer directly owned 55,310 shares of the company’s stock, valued at approximately $5,214,073.70. The trade was a 63.89% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold a total of 184,683 shares of company stock worth $17,486,693 over the last quarter. 0.41% of the stock is owned by corporate insiders.

Key Headlines Impacting Colgate-Palmolive

Here are the key news stories impacting Colgate-Palmolive this week:

Colgate-Palmolive Trading Down 1.9%

Shares of CL stock opened at $97.23 on Tuesday. Colgate-Palmolive Company has a 1-year low of $74.54 and a 1-year high of $100.18. The firm has a market cap of $78.37 billion, a PE ratio of 37.11, a price-to-earnings-growth ratio of 4.47 and a beta of 0.28. The company has a 50-day moving average of $87.86 and a two-hundred day moving average of $82.78. The company has a debt-to-equity ratio of 18.82, a current ratio of 0.83 and a quick ratio of 0.54.

Colgate-Palmolive (NYSE:CLGet Free Report) last issued its quarterly earnings data on Friday, January 30th. The company reported $0.95 EPS for the quarter, topping the consensus estimate of $0.91 by $0.04. Colgate-Palmolive had a net margin of 10.45% and a return on equity of 353.72%. The firm had revenue of $5.23 billion for the quarter, compared to analyst estimates of $5.13 billion. During the same period in the prior year, the business posted $0.91 EPS. The business’s revenue for the quarter was up 5.8% compared to the same quarter last year. On average, analysts predict that Colgate-Palmolive Company will post 3.75 EPS for the current year.

Colgate-Palmolive Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Friday, February 13th. Stockholders of record on Wednesday, January 21st were given a dividend of $0.52 per share. This represents a $2.08 annualized dividend and a dividend yield of 2.1%. The ex-dividend date was Wednesday, January 21st. Colgate-Palmolive’s dividend payout ratio (DPR) is currently 79.39%.

Analyst Ratings Changes

A number of research analysts have weighed in on CL shares. Weiss Ratings reissued a “hold (c)” rating on shares of Colgate-Palmolive in a research note on Wednesday, January 21st. Wells Fargo & Company lifted their price objective on Colgate-Palmolive from $86.00 to $94.00 and gave the stock an “equal weight” rating in a research report on Sunday, February 1st. The Goldman Sachs Group restated a “buy” rating and issued a $100.00 target price on shares of Colgate-Palmolive in a report on Friday, February 20th. JPMorgan Chase & Co. lifted their price target on Colgate-Palmolive from $93.00 to $97.00 and gave the stock an “overweight” rating in a report on Monday, February 2nd. Finally, TD Cowen reissued a “buy” rating on shares of Colgate-Palmolive in a report on Monday, February 2nd. Eleven investment analysts have rated the stock with a Buy rating and six have given a Hold rating to the company’s stock. Based on data from MarketBeat.com, Colgate-Palmolive has an average rating of “Moderate Buy” and an average target price of $94.75.

Get Our Latest Analysis on Colgate-Palmolive

About Colgate-Palmolive

(Free Report)

Colgate-Palmolive Company is a global consumer products company with a long history in household and personal care categories. The business traces its roots to the early 19th century and has evolved into a multinational manufacturer and marketer of everyday consumer goods focused on health, hygiene and home care.

The company’s core activities center on oral care, personal care, home care and pet nutrition. Its product portfolio includes toothpaste, toothbrushes and mouthwash in oral care; soaps, body washes and deodorants in personal care; dishwashing liquids, surface cleaners and other household products in home care; and scientifically formulated pet foods under its pet nutrition business.

Featured Stories

Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive Company (NYSE:CLFree Report).

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.